echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Roche's $450 million acquisition of iquum to enter the market of molecular diagnosis POC

    Roche's $450 million acquisition of iquum to enter the market of molecular diagnosis POC

    • Last Update: 2014-04-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit
    Source: Bio Valley April 7, 2014 / Bio Valley bio on April 7, 2014

    Iqum, located in Massachusetts, USA, focuses on the development of point of care (POC) products for the molecular diagnosis market

    In accordance with the terms of the agreement, Roche will pay iqum's shareholders an upfront payment of $275 million and a contingent payment of $175 million for product related milestones

    Once the deal is completed, iqum will be integrated into Roche molecular diagnostics

    The acquisition will enable Roche to quickly enter the POC segment of molecular diagnosis

    Roche will obtain iqum's Liat system (laboratory in-a-tube), which enables nurses to carry out rapid molecular diagnosis tests in closer proximity to the patient's nursing site with minimal training

    Liat analyzer and Liat influenza A / b kit are the first products developed by using Liat system, which can provide reliable and accurate diagnostic results comparable to laboratory tests

    At present, this product has been CE marked and approved by FDA

    Roland diggelmann, chief operating officer of Roche Diagnostics, said that with the acquisition of iqulum, Roche will further strengthen its molecular diagnostics division with cutting-edge technologies and products serving the POC segment

    Patients will benefit from accurate on-the-spot diagnosis, which enables healthcare professionals to make quick and informed treatment decisions in a flexible environment

    About POCT: POCT (point of care testing) is a new mobile testing mode

    Not only the professional medical staff, but also the patients and their families who have received simple training can complete the POCT independently and obtain the information that is helpful for clinical diagnosis

    POCT is not only fast but also on-site analysis, which can not be realized by other inspection methods.
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.